Cancer as a Metabolic Disease: Insights from Dr. Thomas Seyfried
In this episode of the Keto Made Simple podcast, Dr. Eric Westman interviews Dr. Thomas Seyfried, a leading researcher in cancer metabolism. Dr. Seyfried challenges the traditional somatic mutation theory of cancer and proposes a metabolic-centric approach to treatment.
The Core Thesis: Metabolic vs. Genetic
Dr. Seyfried argues that cancer is caused by chronic damage to the mitochondria (the cell's power plants), specifically the process of oxidative phosphorylation (OxPhos).
- The Warburg Effect: Building on the work of Otto Warburg, Seyfried explains that cancer cells compensate for damaged respiration by switching to fermentation—a way of creating energy without oxygen [00:11:54].
- The "Nail in the Coffin" for Gene Theory: Seyfried cites nuclear transfer experiments where a cancer nucleus placed into a healthy cell (with healthy mitochondria) results in normal growth, whereas healthy nuclei placed into cancer cytoplasm result in cancer [00:35:25].
- Epiphenomena: He asserts that the millions of genetic mutations found in tumors are actually downstream effects of mitochondrial distress and the production of Reactive Oxygen Species (ROS), not the primary cause of the disease [00:38:02].
The Two Primary Fuels of Cancer
According to Dr. Seyfried, cancer cells are "locked in" to a fermentation metabolism and are strictly dependent on two fermentable fuels:
- Glucose (Sugar)
- Glutamine (Amino Acid)
He notes that unlike normal cells, cancer cells cannot effectively survive on non-fermentable fuels like ketone bodies or fatty acids [00:42:06].
The "Press-Pulse" Therapeutic Strategy
Dr. Seyfried introduces the Press-Pulse method as a non-toxic framework for managing cancer [00:23:14]:
- The Press: Using metabolic interventions (ketogenic diet, fasting, or calorie restriction) to chronically lower blood glucose and elevate ketones. This puts metabolic stress on the tumor cells while nourishing normal cells [00:24:13].
- The Pulse: Utilizing strategic, short-term "pulses" of drugs (like DON - 6-Diazo-5-oxo-L-norleucine) to target glutamine. These pulses are timed to minimize toxicity to the immune system and gut [00:25:21].
Key Tools and Metrics
- GKI (Glucose Ketone Index): A tool to track the ratio of blood glucose to ketones. Dr. Seyfried suggests aiming for a GKI of 2.0 or below to maximize therapeutic pressure on tumors [00:59:06].
- Nutritional Ketosis: Achieving a state where the body runs on ketones makes drugs and even standard treatments like radiation more effective at lower, less toxic doses [00:59:34].
Summary Table
| Concept | Traditional View | Seyfried's View |
|---|---|---|
| Origin | Genetic mutations in the nucleus | Mitochondrial metabolic dysfunction |
| Primary Fuel | Broad/Genetic drivers | Glucose and Glutamine (Fermentation) |
| Treatment | Toxic Chemo/Radiation (Targeting DNA) | Press-Pulse (Targeting Fuel/Metabolism) |
| Goal | Eradication of "broken" genes | Management/Remission via metabolic stress |
For more information on Dr. Seyfried's research, visit the Boston College Cancer Research Program or explore his book, "Cancer as a Metabolic Disease."
Watch the full video: YouTube Link